Personal information

Other IDs

Scopus Author ID: 57203659087

Activities

Collapse all

Works (17)

Cardiovascular toxicity induced by immunotherapy in non-small cell lung cancer: a systematic review and meta-analysis of observational studies

Frontiers in Oncology
2025-02-24 | Journal article
DOI: 10.3389/fonc.2025.1528950
Part of ISSN: 2234-943X
Contributors: Josep Sabaté-Ortega; Eduard Teixidor-Vilà; Èlia Sais; Alejandro Hernandez-Martínez; Claudia Montañés-Ferrer; Núria Coma; Emma Polonio-Alcalá; Victor Pineda; Joaquim Bosch-Barrera
Source: Self-asserted source
Alejandro Hernandez-Martinez

Lung cancer survival trends and prognostic factors: A 26-year population-based study in Girona Province, Spain.

Lung cancer (Amsterdam, Netherlands)
2024-10 | Journal article
DOI: 10.1016/j.lungcan.2024.107995
PMID: 39447337
Contributors: Teixidor-Vilà E; Trallero J; Puigdemont M; Vidal-Vila A; Hernandez-Martínez A; Sais E; Sabaté-Ortega J; Verdura S; Menendez JA; Bosch-Barrera J et al.
Source: Self-asserted source
Alejandro Hernandez-Martinez via Europe PubMed Central

Stratification of radiosensitive brain metastases based on an actionable S100A9/RAGE resistance mechanism

Nature Medicine
2022-04 | Journal article
DOI: 10.1038/s41591-022-01749-8
Part of ISSN: 1078-8956
Part of ISSN: 1546-170X
Contributors: Cátia Monteiro; Lauritz Miarka; María Perea-García; Neibla Priego; Pedro García-Gómez; Laura Álvaro-Espinosa; Ana de Pablos-Aragoneses; Natalia Yebra; Diana Retana; Patricia Baena et al.
Source: Self-asserted source
Alejandro Hernandez-Martinez
grade
Preferred source (of 2)‎

1272P First results of the early onset lung cancer (EOLUNG) study to characterize genomic alterations using FoundationOne CDx in young patients with non-small cell lung cancer

Annals of Oncology
2021-09 | Journal article
DOI: 10.1016/j.annonc.2021.08.1874
Part of ISSN: 0923-7534
Contributors: M. Jove Casulleras; J. Bosch Barrera; E. Sais; A. Hernandez; M. Gasusachs; E. Carcereny; T. Moran; M. Domenech Vinolas; R. Palmero; J. Brenes et al.
Source: Self-asserted source
Alejandro Hernandez-Martinez

Silibinin Suppresses Tumor Cell-Intrinsic Resistance to Nintedanib and Enhances Its Clinical Activity in Lung Cancer

Cancers
2021-08-19 | Journal article
DOI: 10.3390/cancers13164168
Part of ISSN: 2072-6694
Contributors: J Bosch-Barrera; Sara Verdura; José Carlos Ruffinelli; Enric Carcereny; Elia Sais; Elisabet Cuyàs; Ramon Palmero; Eugeni Lopez-Bonet; Alejandro Hernández-Martínez; Gloria Oliveras et al.
Source: Self-asserted source
Alejandro Hernandez-Martinez
grade
Preferred source (of 2)‎

P52.05 Lung Cancer Symptoms at Diagnosis: Data from the Thoracic Tumors Registry (TTR Study).

Journal of Thoracic Oncology
2021-03 | Journal article
DOI: 10.1016/j.jtho.2021.01.918
Part of ISSN: 1556-0864
Contributors: V. Calvo; A. Ruano-Ravina; E. Carcereny; T. Moran; D. Rodríguez-Abreu; R. López-Castro; E. Cuadrado-Albite; M. Guirado; L. Gomez-Gonzalez; B. Massuti et al.
Source: Self-asserted source
Alejandro Hernandez-Martinez

69P TGFBI promoter methylation validation as an epigenetic biomarker for trastuzumab resistance in HER2+ breast cancer patients cohort

Annals of Oncology
2020-05 | Journal article
DOI: 10.1016/j.annonc.2020.03.203
Part of ISSN: 0923-7534
Contributors: H. Pla; Á. Díaz-Lagares; A. Hernandez; G. Oliveras; F. Pérez-Bueno; M. Esteller; T. Puig; S. Palomeras; G. Viñas
Source: Self-asserted source
Alejandro Hernandez-Martinez

Epigenetic silencing of TGFBI confers resistance to trastuzumab in human breast cancer

Breast Cancer Research
2019-12 | Journal article
DOI: 10.1186/s13058-019-1160-x
Part of ISSN: 1465-542X
Contributors: Sònia Palomeras; Ángel Diaz-Lagares; Gemma Viñas; Fernando Setien; Humberto J. Ferreira; Glòria Oliveras; Ana B. Crujeiras; Alejandro Hernández; David H. Lum; Alana L. Welm et al.
Source: Self-asserted source
Alejandro Hernandez-Martinez
grade
Preferred source (of 2)‎

EP1.12-15 Oncologic Treatments and Outcomes for Small-Cell Lung Cancer Patients with Brain Metastases

Journal of Thoracic Oncology
2019-10 | Journal article
DOI: 10.1016/j.jtho.2019.08.2260
Part of ISSN: 1556-0864
Contributors: J. Bosch-Barrera; A. Hernandez; N. Priego; M. Puigdemont; E. Sais; N. Quer; A. Izquierdo; E. Cuyàs; H. Pla; A. Roqué et al.
Source: Self-asserted source
Alejandro Hernandez-Martinez

P1.01-54 Somatic Genome Alterations in Lung Cancer Patients Diagnosed with Li Fraumeni Syndrome

Journal of Thoracic Oncology
2019-10 | Journal article
DOI: 10.1016/j.jtho.2019.08.769
Part of ISSN: 1556-0864
Contributors: M. Jove; T. Moran; A. Teule; M. Menendez; M. Gausachs; N. Vilariño; R. Palmero Sánchez; B. Cirauqui; A. Estival; E. Carcereny et al.
Source: Self-asserted source
Alejandro Hernandez-Martinez

P2.01-49 Targeting STAT3-Positive Reactive Astrocytes with Silibinin in the Therapeutic Landscape of Non-Small-Cell Lung Cancer with Brain Metastases

Journal of Thoracic Oncology
2019-10 | Journal article
DOI: 10.1016/j.jtho.2019.08.1392
Part of ISSN: 1556-0864
Contributors: J. Bosch-Barrera; N. Priego; M. Puigdemont; E. Sais; N. Quer; A. Izquierdo; A. Hernandez; E. Cuyàs; A. Carbó; E. Teixidor et al.
Source: Self-asserted source
Alejandro Hernandez-Martinez

Predictive factors of response to immunotherapy in 198 patients with metastatic non-microcytic lung cancer (mNSCLC): Real world data from 2 university hospitals in Spain

Annals of Oncology
2019-10 | Journal article
DOI: 10.1093/annonc/mdz239.043
Part of ISSN: 0923-7534
Contributors: J.F. Cordoba Ortega; A. Gasol Cudos; S. Morales Murillo; O. Pallise; M.A. Salud Salvia; J. Brunet Vidal; H. Pla Juher; A. Carbó Bagué; R. Porta Balanya; A. Izquierdo Font et al.
Source: Self-asserted source
Alejandro Hernandez-Martinez

Immune-related adverse events and atypical radiological response with checkpoint inhibitor immunotherapy in an elderly patient with high PD-L1 expressing lung adenocarcinoma

Oncotarget
2018-08-31 | Journal article
DOI: 10.18632/oncotarget.25984
Part of ISSN: 1949-2553
Contributors: Eduard Teixidor; Elia Sais; Carmen Amalia Vásquez; Walter Carbajal; Alejandro Hernández; Gloria Sánchez; Angel Izquierdo; Sara Verdura; Javier A. Menéndez; Joaquim Bosch-Barrera
Source: Self-asserted source
Alejandro Hernandez-Martinez

Probable drug–drug interaction between erlotinib and amiodarone causes severe neurotoxicity in a patient with advanced lung cancer

Anti-Cancer Drugs
2018-04 | Journal article
DOI: 10.1097/cad.0000000000000600
Part of ISSN: 0959-4973
Contributors: Maria López Brunsó; Cristina Toro Blanch; Elia Sais Girona; Diana Roa García; Alejandro Hernández Martínez; Angel Izquierdo Font; Silvia Guerra Prió; Huber Gunter Mas Pueyo; Joaquim Bosch-Barrera
Source: Self-asserted source
Alejandro Hernandez-Martinez
grade
Preferred source (of 2)‎

P1.03-035 Efficacy of Nintedanib and Docetaxel in Combination with the Nutraceutical Use of Silibinin in Advanced NSCLC

Journal of Thoracic Oncology
2017-11 | Journal article
DOI: 10.1016/j.jtho.2017.09.839
Part of ISSN: 1556-0864
Contributors: J. Bosch Barrera; E. Sais; S. Verdura; E. Cuyas; D. Roa; A. Hernández; A. Izquierdo; E. Teixidor; W. Carbajal; M. Lopez et al.
Source: Self-asserted source
Alejandro Hernandez-Martinez

Effect of silibinin nutraceutical supplementation in brain metastases of patients with advanced lung cancer

Annals of Oncology
2017-09 | Journal article
DOI: 10.1093/annonc/mdx366.035
Part of ISSN: 0923-7534
Contributors: J. Bosch-Barrera; E. Sais; A. Izquierdo; A. Hernández; D. Roa; E. Cuyas; S. Pedraza; N. Priego; P. Ortuño; G. Sánchez et al.
Source: Self-asserted source
Alejandro Hernandez-Martinez

PO-074: Outcome of patients with T1-T2 laryngeal carcinoma treated with laser surgery vs radiotherapy

Radiotherapy and Oncology
2015-02 | Journal article
DOI: 10.1016/s0167-8140(15)34834-9
Part of ISSN: 0167-8140
Contributors: F. Holguin; J. Marruecos; C. Urbano; M. Tobed; A. Hernandez; I. Diez; J. Rubio
Source: Self-asserted source
Alejandro Hernandez-Martinez
How many people are using ORCID?